GL1X · GenesisL1 explorer

Research workbench

Crystal structure of dimeric rxralpha-lbd complexed with partial agonist cbt-pmn and SRC1

Analyse Crystal structure of dimeric rxralpha-lbd complexed with partial agonist… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6L6K
Type
protein
Length
219 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Retinoic acid receptor rxr-alpha; Nuclear receptor coactivator 1
EC
2.3.1.48
UniProt
P19793
Ligands
9HF, CA
Pockets
2 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 71% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARetinoic acid receptor rxr-alphaprotein21071% helix, 3% strandP19793
BNuclear receptor coactivator 1 (EC 2.3.1.48)protein978% helix, 0% strand—

Ligands and binding sites

  • 9HF · 1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl) benzotriazole-5-carboxylic acid · ligand · chains A
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12870.820.92399HF
2690.330.7618empty

Interfaces

1 interface between chains.

  • A–B · 540 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 6L6K · Crystal structure of dimeric RXRalpha-LBD complexed with partial agonist CBt-PMN and SRC1 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.